Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
Understanding of the molecular mechanisms of prostate cancer has led to development of therapeutic strategies targeting androgen receptor (AR). These androgen-receptor signaling inhibitors (ARSI) include androgen synthesis inhibitor-abiraterone and androgen receptor antagonists-enzalutamide, apaluta...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/be6b500cf3f34a71965605d8b1c7087c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|